RxDoctor Payments Data

Katelyn Stenger, APRN

Psychiatric/Mental Health · Uniontown, OHNPI 1417201617

Payments from drug & device makers

$972in general payments, 2019–2025

Across 45 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$265
  • Indivior Inc.$113
  • Axsome Therapeutics, Inc.$108
  • Alkermes, Inc.$105
  • E.r. Squibb & Sons, L.L.C.$99
  • Otsuka America Pharmaceutical, Inc.$60
  • plus $222 from 7 others

What the payments were for

  • Food & beverage$972100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$972 in reported general payments places this provider in the 60th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$10,776
Medicare patients
42
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate44$372,554
Invega SustennaPaliperidone Palmitate22$75,774
RexultiBrexpiprazole38$61,582
PerserisRisperidone18$56,100
VraylarCariprazine Hcl27$39,847
AristadaAripiprazole Lauroxil12$36,653
CaplytaLumateperone Tosylate13$22,076
Paliperidone ErPaliperidone59$19,226
Aripiprazole198$13,949
TrintellixVortioxetine Hydrobromide13$11,201
Ziprasidone Hcl47$5,612
Asenapine Maleate27$4,670
Duloxetine Hcl164$4,540
Atomoxetine Hcl55$4,279
Clozapine17$4,187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$29$372,55444 claims
Johnson & JohnsonInvega Sustenna$47$75,77422 claims
Otsuka America Pharmaceutical, Inc.Rexulti$60$61,58238 claims
Indivior Inc.Perseris$113$56,10018 claims
AbbVieVraylar$31$39,84727 claims
Alkermes, Inc.Aristada$105$36,65312 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$20$22,07613 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$17$11,20113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Uniontown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →